Evidence map›Paper›PMID 32155175›Full record

ArticlePloS one2020

Epidemiological survey of serum titers from adults against various Gram-negative bacterial V-antigens.

Mao Kinoshita, Masaru Shimizu, Koichi Akiyama, Hideya Kato, Kiyoshi Moriyama, Teiji Sawa

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mao KinoshitaDepartment of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Masaru ShimizuDepartment of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Koichi AkiyamaDepartment of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Hideya KatoDepartment of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kiyoshi MoriyamaDepartment of Anesthesiology, School of Medicine, Kyorin University, Tokyo, Japan.
Teiji SawaDepartment of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.ORCID 0000-0001-9558-9011
Kyoto Prefectural University of Medicine · JPKyorin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The V-antigen, a virulence-associated protein, was first identified in Yersinia pestis more than half a century ago. Since then, other V-antigen homologs and orthologs have been discovered and are now considered as critical molecules for the toxic effects mediated by the type III secretion system during infections caused by various pathogenic Gram-negative bacteria. After purifying recombinant V-antigen proteins, including PcrV from Pseudomonas aeruginosa, LcrV from Yersinia, LssV from Photorhabdus luminescens, AcrV from Aeromonas salmonicida, and VcrV from Vibrio parahaemolyticus, we developed an enzyme-linked immunoabsorbent assay to measure titers against each V-antigen in sera collected from 186 adult volunteers. Different titer-specific correlation levels were determined for the five V-antigens. The anti-LcrV and anti-AcrV titers shared the highest correlation with each other with a correlation coefficient of 0.84. The next highest correlation coefficient was between anti-AcrV and anti-VcrV titers at 0.79, while the lowest correlation was found between anti-LcrV and anti-VcrV titers, which were still higher than 0.7. Sera from mice immunized with one of the five recombinant V-antigens displayed cross-antigenicity with some of the other four V-antigens, supporting the results from the human sera. Thus, the serum anti-V-antigen titer measurement system may be used for epidemiological investigations of various pathogenic Gram-negative bacteria.

Indexed as

Surveys and QuestionnairesAdultAgedAged, 80 and overAge DistributionAmino Acid SequenceAnimalsAntigens, BacterialCross ReactionsFemaleGram-Negative BacteriaGram-Negative Bacterial InfectionsHumansImmunizationMaleMice, Inbred ICRAntigens, Bacterial

Identifiers

PMID32155175
PMCPMC7064248
OpenAlexW3011526046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.